In the News... Walmart's new insulin, Omnipod 5 studies, stem cell updates & more!
Diabetes Connections | Type 1 Diabetes
Release Date: 07/02/2021
The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice
Diabetes Connections | Type 1 Diabetes
In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There’s no other insulin on the market quite like this long-acting – and it turns out the community wasn’t letting it go without a fight. My guests are going to tell you more about why. I’m taking to Alison Smart, founder of Choice – her daughter lives with type 1 as well as two doctors: Florence Brown and Amy Valent. Dr. Brown is Co-Director Joslin and BIDMC Diabetes in Pregnancy Program, Assistant Professor of Medicine, Harvard Medical School. Dr. Valent...
info_outline
BONUS Episode: TempraMed wants to pair smart insulin tracking with temperature protection
Diabetes Connections | Type 1 Diabetes
I’ve been talking to the folks at VIVI Cap for a few years now, it’s been fun watching their progress. I wanted to catch up and find out more about what they’ve been up to when it comes to insulin storage – especially as we get closer to the hot summer months. They launched new products in the last year – smart insulin storage that helps you track dosing and a new case with more cooling protection. My guest is Ron Nagar, the founder and CEO of TempraMed, the company that makes the VIVI Cap. This podcast is not intended as medical advice. If you have those kinds of questions,...
info_outline
In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more!
Diabetes Connections | Type 1 Diabetes
It's In the News! Every other week we bring you the top diabetes stories and headlines happening now. This week's top stories: stem cell reserach updates, the Pivot patch pump gets FDA approval, GLP-1 Resistance research moves forward, T1D kids in VA get a big win, time of day for exercise matters, and much more! Don't miss our 2026 events - Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures The best way to keep up with Stacey and the show...
info_outline
Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM
Diabetes Connections | Type 1 Diabetes
We've got an update on Eversense—the CGM that sits just below the skin and lasts a year. This is the first time we’re talking to the folks from Senseonics, the company that makes Eversense, since they spun off from Ascensia. What's changed? It’s also the first time, we’re talking to someone who uses Eversense with an insulin pump – it’s now compatible with the twiist pump. I ask your questions about all of this – how’s the pump integration in real life, when will the next iterations of Eversense be out, their success in the type 2 market and much more. We're talking to Chief...
info_outline
More Than Babysitting: The Power of Type One Together with Raquel Baron
Diabetes Connections | Type 1 Diabetes
Today on Diabetes Connections.. a bonus episode all about finding support and community online and in real life. Seems to be a theme lately and I could NOT be happier. Type One Together started with one college student, a few babysitting jobs, and a realization that there was a need. Type One Together has become something much bigger – they’ll still help you find a sitter but they’re also a hub for T1D info, support and gatherings. I’m talking to the founder, Raquel Baron, about how they got there, what kind of help they provide and what’s next. This podcast is not intended as...
info_outline
In the News... Insulin Act, weekly basal approved, weight loss pill okayed, gene therapy for T1D and more!
Diabetes Connections | Type 1 Diabetes
It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Senate Insulin Act moves forward, FDA approveds Awiqli for type 2 and and second oral GLP-1 pill, lots of updates on stem cell and gene therapy for type 1, updates from Beta Bionics, veterans group and Dexcom team up, and Omnipod features on Scrubs. Much more in the episode! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures The best way...
info_outline
Grownup T1Ds: The Missing Support for Adults Living with Diabetes
Diabetes Connections | Type 1 Diabetes
There’s a reason we don’t call it juvenile diabetes anymore. We all know you grow up and T1D doesn’t go anywhere, and that you can be diagnosed at any age. But it often feels like adults are forgotten. I hope that’s not the case here—but I hear it all the time in the broader community. Kelly Dawes is working to change that. She’s started GrownUp T1Ds, a community built specifically for adults who’ve been living with type 1 for years and are finally finding connection, understanding, and support in a way they may never have had before. This podcast is not intended as medical...
info_outline
In the News... the "Next Ozempic" moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more
Diabetes Connections | Type 1 Diabetes
It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about...
info_outline
Are We Finally Taking Mental Health Seriously in Diabetes Care?
Diabetes Connections | Type 1 Diabetes
We all know how important mental health is but unless you are VERY lucky, you’re on your own. There are the rare programs out there for pediatric endocrinology and we’ve got one of the best Dr. Taylor Stephens is a pediatric psychologist with the Cleveland Clinic who specializes in pediatric endocrinology conditions. She’s here to share what we can all do, right after diagnosis, and years later to support our kids and ourselves, if you're a caregiver or an adult living with type 1 This podcast is not intended as medical advice. If you have those kinds of questions, please contact...
info_outline
BONUS Episode: Dexcom Updates From ATTD with Jessica Castle, VP of Medical Affairs
Diabetes Connections | Type 1 Diabetes
Bonus episode! I had the opportunity to talk to the folks at Dexcom about their presentations at ATTD and I wanted to bring you the interview sooner rather than later. ATTD is the Advanced Technology and Treatments for Diabetes conference, this year it took place in Barcelona. If you’re new around here, there are a few big diabetes conferences where studies are presented and news is made. ATTD in spring, ADA and ADCES in summer and a few more scattered here and there. We’ll be sharing more from ATTD in upcoming interviews with other tech companies. But today I’m talking to Jessica...
info_outlineCheck out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----
Get the App and listen to Diabetes Connections wherever you go!
Click here for iPhone Click here for Android
Transcription below:
Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.
XX
In the News is brought to you by Inside the Breakthrough. A new history of science podcast full of “Did You Know… Stuff”
XX
The top story this week - Walmart launches the first-ever and only private brand analog insulin at a discount off the list price.
This new brand ReliOn Novolog will have vials priced at $72 and a package of pens at $85 – compared to the list price of $289 and $558 respectively
Walmart worked directly with Novo Nordisk for the manufacturing of this insulin which will be in regular stores this week and in Sam's Club locations in mid-July.
Interestingly, this price is not below the one offered already by using coupons from groups like GoodRX or even the insulin manufacturers assistance programs. If you need help paying for your insulin, I’ll link up more info on that as well.
https://www.goodrx.com/novolog
XX
As expected, loads of info and studies from the ADA scientific sessions virtual conference that just wrapped up. Please check the links I’ll include because these are just highlights.
XX
Insulet is out with the results of their latest pivotal trial for the Omnipod 5 Automated Insulin Delivery System in very young children. The system improved time in range and reduced A1C in children 2 through just under six. I can tell you from experience, this is a tough age group for many reasons, including the fact that they can’t self-treat or really tell you what’s going on.
Parents and caregivers reported significantly improved sleep quality
Another Omipod 5 study with people aged 6 through 70 showed similar improvements. The system is awaiting FDA approval.
XX
ViaCyte, Inc. released preliminary clinical data from its stem cell-derived islet cell replacement therapy for people with type 1 diabetes. They show the implanted pancreatic cells produced their own insulin – which increase glucose-responsive C-peptide levels, increased time in range, and reduced A1C.
This method protects the stem cells in a pouch – that’s put very simply – Viactye is working on several different methods toward a functional cure.
https://www.prnewswire.com/news-releases/viacyte-reports-compelling-preliminary-clinical-data-from-islet-cell-replacement-therapy-for-patients-with-type-1-diabetes-301320084.html
XX
Another company on the same track.. Sernova Corp also showing their Cell Pouch transplanted with insulin-producing islets is safe and effective. One patient has finished the trial and has now remained insulin independent – that means no requirement for injectable insulin - for 14 months with optimal glucose control.
This is a person who’s lived with type 1 for 47 years..
https://www.thenewswire.com/press-releases/1k3wFKYMv-sernovas-principal-investigator-presents-interim-data-and-positive-patient-outcomes-of-phase-i-ii-t1d-study-at-the-american-diabetes-association-81st-scientific-sessions.html
XX
More from ADA conference - In two small studies, the ultra-rapid acting insulin Afrezza was found to be safe in children with type 1 and adults with type 2 diabetes.
Inhalable insulin is currently only approved for adults so the goal here was to look at safety.. which looks good. But it’s also worth noting that . Time in Range increased from 39% at baseline to 62% which is more than four additional hours spent in range each day!
https://diatribe.org/top-highlights-day-1-ada-scientific-sessions-2021
XX
New info in on Medtronic’s Extended-Wear Infusion Set. This is the pump inset that lasts seven days. This study shows that 75% of the time it makes it to the full seven days – Medtronic’s 3 day infusion sets have a 67% survival rate.
Device failure rates were very low – 8 cases out of more than 3-thousand sessions. Satisfaction was high – with people citing convenience of use, ease of insertion, and comfort of wear. This extended wear set is approved in Europe, available in Finland and has been submitted to the US FDA.
https://diatribe.org/day-2-3-highlights-ada-scientific-sessions-2021
XX
More to come, including news on Control IQ and an endurance athlete starts an amazing new trek.. but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.
- Inside the Breakthrough is a podcast that mixes historical wisdom with modern insight – it’s a science show that’s also entertaining. I love it. They cover everything from snake oil to the actual Eureka moment. There’s even an episode about the guy who discovered the importance of hand washing in hospitals and how no one believed him. And this all actually relates to diabetes! Listen to Inside the Breakthrough wherever you listen to podcasts..
Back to the news…
XX
Control-IQ continues to get high marks. This study looked at adults with an average age of 70 who already had A1Cs around 6.9. Three months after staring Control IQ, time in range increased from 64% to 87% which is 5 and a half hours more each day. All of these adults had prior experience with continuous glucose monitoring and insulin pumps.
XX
Former guest of the podcast, Sébastien Sasseville, is off on a mission to cycle across Canada in 14 days! Sasseville is a Canadian endurance athlete – he lives with type 1 - and it’s going to take about 250 miles a day to get to this goal.
Sasseville says he’s riding to bring attention to the issue of access to technology – he uses the tslim x2 and Dexcom G6 – and to support JDRF Canada’s Access for All campaign. He set off on June 28th and is documenting the journey on social media.
Sebastien Sasseville cycles across Canada: https://www.facebook.com/CanadaRuns.
That’s Diabetes Connections – In the News. If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com.
Please join me wherever you get podcasts for our next episode -Tuesday – a conversation with Dexcom’s CEO all about the upcoming G7.. I asked him all of your questions.
Our current episode out right now is with Nick Jonas – sharing his thoughts on the new campaign to educate about Time in Range and talking about he manages his T1D during concerts, shooting movies and during TV tapings.
Thanks and I’ll see you soon